- Home
- SABR vs BLFS Comparison
SABR vs BLFS Comparison
Compare SABR & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SABR
- BLFS
- Stock Information
- Founded
- SABR 2006
- BLFS 1987
- Country
- SABR United States
- BLFS United States
- Employees
- SABR N/A
- BLFS N/A
- Industry
- SABR Computer Software: Programming Data Processing
- BLFS Medical/Dental Instruments
- Sector
- SABR Technology
- BLFS Health Care
- Exchange
- SABR Nasdaq
- BLFS Nasdaq
- Market Cap
- SABR 1.0B
- BLFS 1.0B
- IPO Year
- SABR 2014
- BLFS 1989
- Fundamental
- Price
- SABR $3.11
- BLFS $21.64
- Analyst Decision
- SABR Hold
- BLFS Strong Buy
- Analyst Count
- SABR 5
- BLFS 7
- Target Price
- SABR $4.12
- BLFS $30.57
- AVG Volume (30 Days)
- SABR 5.8M
- BLFS 622.4K
- Earning Date
- SABR 07-31-2025
- BLFS 08-07-2025
- Dividend Yield
- SABR N/A
- BLFS N/A
- EPS Growth
- SABR N/A
- BLFS N/A
- EPS
- SABR N/A
- BLFS N/A
- Revenue
- SABR $3,023,296,000.00
- BLFS $87,762,000.00
- Revenue This Year
- SABR $2.85
- BLFS $21.21
- Revenue Next Year
- SABR $3.47
- BLFS $17.58
- P/E Ratio
- SABR N/A
- BLFS N/A
- Revenue Growth
- SABR 2.56
- BLFS 34.80
- 52 Week Low
- SABR $1.93
- BLFS $18.70
- 52 Week High
- SABR $4.63
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- SABR 65.67
- BLFS 44.20
- Support Level
- SABR $2.56
- BLFS $20.50
- Resistance Level
- SABR $3.03
- BLFS $22.07
- Average True Range (ATR)
- SABR 0.15
- BLFS 1.02
- MACD
- SABR 0.03
- BLFS -0.10
- Stochastic Oscillator
- SABR 85.94
- BLFS 22.69
About SABR Sabre Corporation
Sabre holds the number-two air booking volume share in the global distribution system industry. The travel solutions segment represented 91% of total 2024 revenue, split between distribution (79% of segment sales) and airline IT solutions (21%) revenue. The company announced a planned sale of its growing hotel IT solutions division (9% of revenue) to TPG for $960 million in net proceeds, which is scheduled to close in late 2025. Transaction fees, which are mostly tied to volume and not price, account for the bulk of sales and profits.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.